Literature DB >> 7620335

Identification of the oligosaccharide structures of human coagulation factor X activation peptide at each glycosylation site.

H Nakagawa1, N Takahashi, K Fujikawa, Y Kawamura, M Iino, H Takeya, H Ogawa, K Suzuki.   

Abstract

Human blood coagulation factor X has two N-linked oligosaccharides at Asn39 and Asn49 residues and two O-linked oligosaccharides at Thr17 and Thr29 residues in the region of the factor X activation peptide (XAP) which is cleaved off during its activation by factor IXa. We determined the structure of oligosaccharides in the XAP region of human factor X. Four glycopeptides each containing a glycosylation site were isolated by digestion of XAP with endoproteinase Asp-N followed by reversed-phase HPLC. N-linked oligosaccharides released from the glycopeptides by glycoamidase A digestion were derivatized with 2-aminopyridine. Pyridylamino(PA)-oligosaccharides were separated by HPLC into neutral and sialyl oligosaccharides using an anion-exchange column. Structures of oligosaccharides and their contents at each glycosylation site were determined by a two-dimensional sugar mapping method. The contents of the neutral oligosaccharides at Asn39 and Asn49 residues were 32.5% and 30.0%, respectively. Six neutral and twelve monosialyl oligosaccharides isolated from both N-linked glycosylation sites showed similar elution profiles composed of bi-, tri- and tetra-antennary complex type oligosaccharides. The predominant component in neutral oligosaccharides was biantennary without a fucose residue. Two major monosialyl oligosaccharides were also biantennary without fucose and with a Neu5Ac alpha 2-->6 residue. In addition, the structures of O-linked oligosaccharides at Thr17 and Thr29 residues were suggested to be disialylated Gal beta 3GalNAc sequences by their component analyses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7620335     DOI: 10.1007/BF00731362

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  22 in total

Review 1.  High-performance anion-exchange chromatography for carbohydrate analysis.

Authors:  Y C Lee
Journal:  Anal Biochem       Date:  1990-09       Impact factor: 3.365

2.  Activation of human factor X (Stuart factor) by a protease from Russell's viper venom.

Authors:  R G Di Scipio; M A Hermodson; E W Davie
Journal:  Biochemistry       Date:  1977-11-29       Impact factor: 3.162

3.  Structure analyses of oligosaccharides by tagging of the reducing end sugars with a fluorescent compound.

Authors:  S Hase; T Ikenaka; Y Matsushima
Journal:  Biochem Biophys Res Commun       Date:  1978-11-14       Impact factor: 3.575

4.  Structures of the sugar chains of interferon-gamma produced by human myelomonocyte cell line HBL-38.

Authors:  S Yamamoto; S Hase; S Fukuda; O Sano; T Ikenaka
Journal:  J Biochem       Date:  1989-04       Impact factor: 3.387

5.  Coagulation factor X activating enzyme from Russell's viper venom (RVV-X). A novel metalloproteinase with disintegrin (platelet aggregation inhibitor)-like and C-type lectin-like domains.

Authors:  H Takeya; S Nishida; T Miyata; S Kawada; Y Saisaka; T Morita; S Iwanaga
Journal:  J Biol Chem       Date:  1992-07-15       Impact factor: 5.157

6.  Two-dimensional elution map of GalNAc-containing N-linked oligosaccharides.

Authors:  N Takahashi; Y Wada; J Awaya; M Kurono; N Tomiya
Journal:  Anal Biochem       Date:  1993-01       Impact factor: 3.365

7.  Calcium binding to a human factor IXa derivative lacking gamma-carboxyglutamic acid: evidence for two high-affinity sites that do not involve beta-hydroxyaspartic acid.

Authors:  T Morita; W Kisiel
Journal:  Biochem Biophys Res Commun       Date:  1985-07-31       Impact factor: 3.575

8.  Structural analysis of N-linked oligosaccharides by a combination of glycopeptidase, exoglycosidases, and high-performance liquid chromatography.

Authors:  N Tomiya; M Kurono; H Ishihara; S Tejima; S Endo; Y Arata; N Takahashi
Journal:  Anal Biochem       Date:  1987-06       Impact factor: 3.365

9.  The role of human factor X activation peptide in activation of factor X by factor IXa.

Authors:  M Iino; H Takeya; J Nishioka; T Nakagaki; K Tamura; K Suzuki
Journal:  J Biochem       Date:  1994-08       Impact factor: 3.387

10.  Analyses of N-linked oligosaccharides using a two-dimensional mapping technique.

Authors:  N Tomiya; J Awaya; M Kurono; S Endo; Y Arata; N Takahashi
Journal:  Anal Biochem       Date:  1988-05-15       Impact factor: 3.365

View more
  2 in total

1.  Structure and dynamics of zymogen human blood coagulation factor X.

Authors:  Divi Venkateswarlu; Lalith Perera; Tom Darden; Lee G Pedersen
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

2.  Mass spectrometry based analysis of human plasma-derived factor X revealed novel post-translational modifications.

Authors:  Guillaume Chevreux; Nolwenn Tilly; Valegh Faid; Nicolas Bihoreau
Journal:  Protein Sci       Date:  2015-09-18       Impact factor: 6.725

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.